Confirmed Summit Speakers, Chairs and Judges
–> Learn more & Register for the 2017 SharpBrains Virtual Summit: Brain Enhancement in the Digital Age (December 5–7th).
Dr. Adam Gazzaley, Professor of Neurology and Founding Director of Neuroscape at UCSF
Dr. Gazzaley is a faculty member in the Neurology, Physiology and Psychiatry departments, and Director of a cognitive neuroscience laboratory conducting research on the neural mechanisms of attention and memory. Dr. Gazzaley is also co-founder and Chief Science Advisor of Akili Interactive Labs, a company developing therapeutic video games, and co-founder and Chief Scientist of JAZZ Venture Partners, a venture capital firm investing in experiential technology to improve human performance. He has received many awards and honors for his research, including the 1997 Cortical Scholar Award, Pfizer/AFAR Innovations in Aging Award and the Ellison Foundation New Scholar Award in Aging.
Dr. Adam Haim, Chief of the Clinical Trials Operations and Biostatistics Branch at the NIMH
Dr. Haim oversees the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs at the National Institute of Mental Health (NIMH). Both programs help small businesses fund R&D with strong potential for technology commercialization, and a significant portion of their current grant portfolio is focused on the development and evaluation of mHealth interventions and digital health technology. Previously, Adam was a Senior Research Fellow at KAI Research and a post doc research fellow at the NIMH, and completed a residency at Baltimore VA Medical Center.
Dr. Albert Kwon, Co-Founder & CEO of AUGMENTx
Dr. Albert Kwon, is an MIT and Harvard trained biologist, pediatrician, and anesthesiologist. After completing his residencies at Brigham and Women’s Hospital and Boston Children’s Hospital, he will further specialize in pain medicine at Stanford. He has extensive basic science and engineering research experience in drug delivery, tissue engineering and regenerative medicine with pioneering researchers at MIT and Harvard. He is the CEO and Medical Director of AUGMENTx.
Alexandra Morehouse, CMO of Banner Health
Alexandra M. Morehouse is Senior Vice President & Chief Marketing Officer for Banner Health, one of the nation’s largest nonprofit health systems. Prior to Banner Health, she was the Vice President of Brand Management at Kaiser Permanente, and CMO of AAA. Ms. Morehouse has also served as co-chair of the Harvard Business School Global Technology Conference and on the boards of the Harvard Business School Community Partners, SnapFish, Yerba Buena Center for the Arts, ODC Dance, and UC Davis. She graduated with high honors from Harvard University and has an MBA from Harvard Business School.
Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)
Dr. Fenney runs the Neurotechnology Industry Organization, a global trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups. Prior to NIO, Alison was Manager of Industry Relations at the Ontario Brain Institute (OBI) in Canada, and also worked in Equity Research at Bloom Burton & Co. She has a PhD in Neuroscience and an MBA from McMaster University, a Masters in Neurokinetics from the University of Quebec at Montreal, and a Bachelor of Kinesiology (honors) from Brock University.
Álvaro Fernández, CEO and Editor-in-Chief of SharpBrains
Álvaro Fernández, a member of the World Economic Forum’s Council on the Future of Human Enhancement, runs SharpBrains, an independent market research firm tracking health and performance applications of brain science. Mr. Fernandez is the co-author of “The SharpBrains Guide to Brain Fitness: How to Optimize Brain Health and Performance at Any Age”, and the Editor-in-chief of SharpBrains’ market report on Pervasive Neurotechnology. Previously he worked in McKinsey & Company, Bertelsmann, Docent and Ashoka: Innovators for the Public, and has an MBA and MA in Education from Stanford University and a BA in Economics from Universidad de Deusto, in his native Spain.
Dr. Álvaro Pascual-Leone, Director of the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center
Dr. Pascual-Leone is a world leader in the development of transcranial magnetic stimulation for application in cognitive neuroscience and for therapeutic applications in neurology, psychiatry, and neurorehabilitation. He is a Professor of Neurology and an Associate Dean for Clinical and Translational Research at Harvard Medical School, and serves as Chief for the Division of Cognitive Neurology and the Director of the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center. Pascual-Leone’s research projects aim at understanding the mechanisms that control brain plasticity across the lifespan to be able to modify them for the subject’s optimal behavioral outcome.
Dr. Amy Serin, Co-Founder & Chief Science Officer at The Touchpoint Solution
Dr. Amy Serin, the current president of the Arizona Neuropsychological Society, is Co-Founder & Chief Science Officer at The Touchpoint Solution. She is credited with inventing BLAST (Bi-Lateral Alternating Stimulation delivered Tactile) technology as part of neuroscience research and practice at The Serin Centers. Dr. Serin oversees research partnerships with Universities across the globe, and is past Valedictorian at ASU, Phoenix Young Woman of The Year and Advocate of The Year.
Dr. Anna Wexler, science writer, filmmaker and postdoc fellow in advanced biomedical ethics at UPenn
Dr. Anna Wexler is a science writer, filmmaker and postdoc fellow in advanced biomedical ethics at the Department of Medical Ethics & Health Policy at the University of Pennsylvania. Her research centers on the ethical, legal and social implications of emerging neurotechnology. Dr. Wexler received her Ph.D. in 2017 from the HASTS (History, Anthropology, Science, Technology & Society) Program at MIT, where she examined do-it-yourself and direct-to-consumer applications of noninvasive brain stimulation. She is currently exploring the ethical and regulatory challenges raised by the full spectrum of interventions used in the home to modify brain function.
Dr. April Benasich, Director of the Infancy Studies Laboratory at the Rutgers Center for Molecular and Behavioral Neuroscience
As director of the Infancy Studies Laboratory at the Rutgers Center for Molecular and Behavioral Neuroscience, Dr. April Benasich’s research focuses on brain development in infancy and early childhood, specifically the neural processes necessary for normal language and cognitive development. She uses a mix of cutting-edge technologies, including measurement of auditory evoked brain potentials (EEG/ERPs) and naturally sleeping MRI/fMRI, that add converging noninvasive physiological measures to her lab’s extensive behavioral battery.
Ariel Garten, Founder and Chief Evangelism Officer at InteraXon
Ariel Garten is the Founder and Chief Evangelism Officer of InteraXon, which creates thought controlled computing products and applications. Ariel has also researched at the Krembil Neuroscience Institute studying hippocampal neurogenesis, displayed work at the Art Gallery of Ontario, been head designer at a fashion label, and opened Toronto Fashion Week. Referred to as the “Brain Guru” by Now Magazine, CBC Radio and the Toronto Star, Ariel has also run a successful real estate business, spent time as the designer and owner of a Canadian fashion boutique, and is a practicing psychotherapist.
Belén Guerra-Carrillo, NSF Fellow and graduate student researcher at University of Califonia, Berkeley
Belen Guerra-Carrillo was recently awarded a fellowship by the National Science Foundation for her graduate research efforts. Her recent achievement earned Guerra-Carrillo a spot on The City University of New York’s new team of award-winning “Science All-Star” students who have won National Science Foundation (NSF) Graduate Research Fellowships, the most prestigious awards a graduate student in the STEM disciplines (science, technology, engineering, and mathematics) can receive. The awards recognize and support exceptional students who have proposed graduate-level research projects in their fields.
Dr. Bill Reichman, President of Baycrest
Dr. Reichman is President and Chief Executive Officer of Baycrest, one of the world’s premier academic health sciences centres focused on aging and brain function. Dr. Reichman, an internationally-known expert in geriatric mental health and dementia is also Professor of Psychiatry on the Faculty of Medicine at the University of Toronto. He is a noted authority on the delivery of mental health and dementia services in nursing home settings. Dr. Reichman is a former President of the American Association for Geriatric Psychiatry and the Geriatric Mental Health Foundation.
Bill Tucker, Senior Advisor to the K12 Education Program at the Bill & Melinda Gates Foundation
Bill Tucker is the senior advisor of K12 Education Programs at the Bill & Melinda Gates Foundation, where he’s responsible for identifying and addressing critical, emerging cross-cutting strategy issues and development of strategic partnerships with key stakeholders, grantees, and local, regional and national funders. Bill is also responsible for K‑12 advocacy/policy grantmaking portfolio, handling a team of six senior program officers and strategic prioritization, budgeting, and allocation of $40+ million grantmaking portfolio. He holds an MBA and MA in Education from Stanford University.
Dr. Bob Bilder, Director of the UCLA Tennenbaum Center for the Biology of Creativity
Dr. Bob Bilder is the Director of the Tennenbaum Center for the Biology of Creativity in the Jane & Terry Semel Institute for Neuroscience and Human Behavior, and the Michael E. Tennenbaum Family Professor of Psychiatry & Biobehavioral Sciences and Chief of Medical Psychology — Neuropsychology at David Geffen School of Medicine. He has received many awards for his research contributions, served on diverse federal and international advisory boards, provided editorial service to many scholarly journals, and received multiple grants from the NIH, private foundations, and industry.
Dr. Bob Schafer, Head of Research at Lumosity
Bob Schafer oversees Research Science and Data Science, combining his background in neuroscience research and product development to help translate scientific knowledge into products for assessing and training mental performance. Prior to Lumos, Bob was the founder and CEO of Prophecy Sciences, a startup using neuroscience and predictive analytics to improve hiring decisions and team development. He earned his PhD in neuroscience from Stanford University, was a postdoctoral fellow at MIT and has published research in journals including Science and Neuron.
Charlie Hartwell, Operating Partner at the Bridge Builders Collaborative
Charlie helps fund and support the visions of social entrepreneurs who have scalable business models for applications, practices, products, and tools that build bridges for mind-training. He is a Harvard Business School graduate who has led, founded, run and worked in organizations in 16 different industries. Previously Charlie was President of Ideas to Go, an innovation-consulting firm. His career has included Wall Street, corporate marketing stints at HJ Heinz and Pillsbury. In 1998, he formed the first for-profit expedition company in the US, helping launch the historic Bancroft Arnesen Expedition across Antarctica by polar explorers Ann Bancroft and Liv Arnesen.
Colin Milner, Founder and CEO of the International Council on Active Aging (ICAA)
Colin Milner is Founder and CEO of ICAA, and a leading authority on the health and well-being of older adults. He has been recognized by the World Economic Forum as one of “the most innovative and influential minds” in the world on aging-related topics. He has been published thought-leadership articles in journals such as Global Policy, and the Annual Review of Gerontology and Geriatrics. Milner’s speeches have stimulated thousands of business and government leaders, industry professionals, and older adults worldwide.
Dr. Corinna Lathan, CEO of AnthroTronix and Co-Chair of the World Economic Forum’s Council on the Future of Human Enhancement
Dr. Corinna Lathan is Co-Founder and CEO of AnthroTronix, Inc., an engineering R&D company creating diverse human-centered products in digital health, wearable technology, robotics, and augmented reality. Most recently, Dr. Lathan led the technical team to develop DANA, an FDA-cleared, digital health software to evaluate cognitive function during treatment for depression, brain injury, and post-traumatic stress. For this work, she was named a 2017 Woman to Watch by Disruptive Women in Health Care. Dr. Lathan is currently co-Chair of the World Economic Forum’s Global Future Council on Human Enhancement and is a thought leader on technology trends that impact health and healthcare.
Dr. Chris Walling, Chairman of the Education Advisory Committee for the Alzheimer’s Research and Prevention Foundation
Chris Walling, PsyD, MBA, C‑IAYT has been an active leader in healthcare for nearly two decades. His work integrates the developmental, biological, and somatic aspects of the lifespan. His work in academic medicine has included the administration of multidisciplinary leadership teams in hematology-oncology, physical medicine and rehabilitation, and geriatric psychiatry. He currently serves as Chairman of the Education Advisory Committee for the Alzheimer’s Research and Prevention Foundation, and is also the President of the United States Association of Body Psychotherapy. His clinical focus in the behavioral sciences has examined the intersections of neuropsychotherapy, affect regulation, and body psychology.
Danny Dankner, CEO of Applied Cognitive Engineering (ACE)
Danny runs Applied Cognitive Engineering (ACE), a cognitive simulations firm that develops specialized “brain gyms” to enhance the performance in high-pressure domains. Previously he was on the founding team of Kinetica Internetting Solutions, directed the Project Management activities at MobileSpear, and had a key role in the merger of G‑sites and Box Interactive, leading to the creation of Scepia Internet Solutions — Israel’s largest solution provider. Danny holds an MBA in Marketing & IT and LL.B, both from Tel Aviv University and an Israeli Bar Diploma. He is a certified system analyst.
Dr. David Bach, Founder & President of the Platypus Institute
Dr. David Bach is a Harvard-trained scientist, physician, and serial entrepreneur. After spending a decade maximizing his physical and mental performance, he created the Platypus Institute to bring scientific rigor to, and create commercial applications in, the rapidly expanding arena of applied neuroscience. As a business entrepreneur, David founded and built three healthcare companies, each of which became a $100M enterprise. He has also been a management consultant, a venture capitalist, a competitive martial artist, and a professional cellist. Dr. Bach has always had a passionate interest in human development.
Dr. David Barash, Chief Medical Officer and Executive Director of Global Health at GE Foundation
David M. Barash, M.D. is the ED of the Global Health Portfolio and Chief Medical Officer for the GE Foundation, where initiatives are approached with the belief that simple interventions, along with strong partnerships and leaders, are often the answer to some of the healthcare’s most complex problems. He is also co-chair of the Private Sector Roundtable, a collaboration of several multinational companies to support the work of the Global Health Security Agenda. Dr. Barash is a practicing emergency medicine physician with more than 30 years’ experience and great interest on understanding how new technologies can be commercialized and delivered to effectively close the gap between brainstorm and bedside.
Dr. David Bartrés-Faz, Principal Investigator of the Barcelona Brain Health Initiative (BBHI)
David Bartrés-Faz is the Principal Investigator of the Barcelona Brain Health Initiative study, a prospective longitudinal cohort investigation debited to study the protective factors as well as the associated brain mechanisms that explain resilience to disease and maintenance of cognitive function with advancing age. He is also the PI of the Barcelona group within the H2020 ‘Lifebrain’ project as well as of a National research study funded by the Spanish Ministry to investigate the putative synergic effects of non-invasive brain stimulation in combination with cognitive training in Mild Cognitive Impairment patients. He is also responsible for the Barcelona Brain Stimulation Lab at the University of Barcelona.
David Klein, Co-Founder & CEO of Click Therapeutics
David is a healthcare investor and entrepreneur with over 15 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, David co-founded Click Therapeutics which focuses on engineering, validating and commercializing Digital TherapeuticsTM solutions to benefit people with unmet needs through cognitive and neurobehavioral modification. He formerly served as Managing Director at a life science asset management firm, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies.
Debra Gilmore, Executive Director of The Arrowsmith Program
Debbie Gilmore is the new Executive Director of Arrowsmith Program, having been Arrowsmith’s representative in Australia and New Zealand for 18 months. Debbie first heard about the Arrowsmith Program when she was Head of Diverse Learning Needs at the Catholic Education Office, Sydney, Australia. Her work as a teacher, literacy adviser, assistant principal and principal helped her understand the need to ‘unlock’ the potential of students with learning difficulties, and her role as a mother of a son with such challenges gave her first hand experience of their struggles. Debbie holds a Masters of Education and various Graduate Certificates in Education.
Dr. Eddie Martucci, CEO of Akili Interactive Labs
Dr. Martucci is co-founder and CEO at Akili Interactive Labs, a digital health company aiming to make the first regulatory-approved diagnostic and therapeutic video games. He spearheaded the clinical partnerships that Akili now has with Pfizer and multiple top-tier academic institutions. Dr. Martucci is also a Principal at PureTech Ventures. He was previously a Kauffman Entrepreneur Fellow. Dr. Martucci completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, and received a BS in Biochemistry from Providence College and a PhD and MPhil from Yale University.
Eduardo Briceño, CEO of Mindset Works
Eduardo is the Co-Founder and CEO of Mindset Works, which he started with Carol Dweck, Lisa Blackwell and others, to help people develop as motivated and effective learners. Prior to Mindset Works, Eduardo was an Education Pioneers Fellow at New Leaders, a Principal with the Sprout Group,and an analyst with Donaldson, Lufkin & Jenrette. Eduardo holds MBA and M.A. in Education degrees from Stanford University, and bachelor’s degrees in Economics and in Engineering from the University of Pennsylvania.
Edward Kliphuis, Investment Director of Merck Ventures
Edward Kliphuis, Investment Director at Merck Ventures and Board Observer at Akili Interactive Labs, looks for new investment opportunities for the 300 million euro Merck Ventures fund. Previously he was at Kempen & Co, a pan European merchant bank headquartered in Amsterdam, the Netherlands, where he worked in the Life Sciences Securities team. Edward was instrumental in the team’s continuous fundraising efforts for listed European small and mid-cap biotech companies in over 20 deals. He holds an M.Sc. degree in Biopharmaceutical Sciences from Leiden University, the Netherlands, with specializations in pharmacology and science-based business.
Dr. Graeme Moffat, Director of Scientific & Regulatory Affairs at InteraXon
Graeme leads health and neuroscience R&D at InteraXon, the maker of Muse: the brain sensing headband. Prior to joining InteraXon, he served as Managing Editor of the Frontiers journal series under the Nature Publishing Group, covering Neuroscience, Neurology, and Psychiatry. Graeme’s experience includes research engineering with CNRS (France) and Neurelec/Oticon Medical on hearing aids and cochlear implants, as well as clinical trial development. He holds a PhD in neuroscience from Université Aix-Marseille and a BSc in physics from McMaster University and is currently a fellow of the Ontario Centres of Excellence in Toronto.
Greg Wong, VP Product Management at Savonix
Mr. Gregory Wong is a multidisciplinary entrepreneur. He has held leadership positions in predictive analytics, medical device, and community health centers. As published author in radiology and as an award-winning presenter on research in mind-body medicine, Mr. Wong found his way to Savonix with a conversation with Dr. Charvat around the importance of cognition in health care. Leading the product drive, he is firm believer that everyone can benefit from knowing this missing vital.
Ignacio de Ramon, Co-Founder & CEO of Sincrolab
Ignacio de Ramón is a Neuropsychologist. PhD Student in Cognitive Neuroscience and Executive MBA by IESE Business School. He has worked for more than 10 years with patients with Neurodevelopmental Disorders in Specialized Centers and as a volunteer in different associations. He is a Professor of Neuropsychological Evaluation in two Spanish Universities and of Entrepreneurship in Industrial Organization School.
Jafar Sabbah, Founder & CEO of Beam Riders
Jafar Sabbah is a seasoned technology and social entrepreneur with more than 20 years of experience. Jafar is the Founder & CEO of Beam Riders, a startup builing a cloud-base tracking system to monitor cognitive skills using EEG and behavioural attributes data. Before that he worked in the fields of internet, biomedical technology, micro-finance, and economic development in addition to a successful legal practice. Jafar has been quoted in leading newspapers and articles around the globe, and is a member of the second class of the Middle East Leadership Initiative of The Aspen Institute and a Fellow of the Aspen Global Leadership Network.
Jan Samzelius, Co-Founder & CEO
Jan has specialized in quantitative methods for 40 years and has invented the typing cadence technology central to NeuraMetrix. He has previously led a large number of analytical projects, ranging from measuring customer satisfaction to price elasticities to conjoint analyses. He has been the CEO of six companies (most of them startups), in several cases improving profits dramatically. His experience includes one turnaround and one successful exit. Jan holds a BSc in economics from the Stockholm School of Economics, graduating with honors and an MBA from Harvard Business School.
Dr. Karen Postal, President of the American Academy of Clinical Neuropsychology (AACN)
Dr. Postal is a board certified in neuropsychology and pediatric neuropsychology, and a clinical instructor at Harvard Medical School, where she teaches postdoctoral fellows in neuropsychology. She also works with students from elementary school through college to overcome barriers to academic success. Dr. Postal has an expertise in working with traumatic brain injury and has been designated a neutral neuropsychologist for the National Football League. She is the author of Feedback that Sticks: The Art of Effectively Communicating Neuropsychological Assessment Results.
Kathleen Herath, Associate Vice President Health & Productivity at Nationwide Insurance
Kathleen Herath oversees the Health and Productivity strategy at Nationwide for the company’s 33,000 associates. She is responsible for the company’s integrated health and productivity program, which includes: health screenings, wellness programs, disability and disease management, health education, work-life resources and walking programs and occupational health clinics. The Health and Productivity program at Nationwide has received numerous national awards for the first four years including the 2009 IBI Health Innovation Award, the American Heart Association’s Platinum Fit-Friendly Employer award, the 2010 HUB magazine APEX award and the prestigious C. Everett Koop National Health Award.
Kayt Sukel, science writer
Kayt Sukel is passionate science writer who has no problem tackling interesting (and often taboo) subjects spanning love, sex, technology, and the brain. Her work has appeared in the Atlantic Monthly, New Scientist, Fortune, Pacific Standard, and the Washington Post, just to name a few. She is the author of the books Dirty Minds: How Our Brains Influence Love, Sex, and Relationships (retitled as This Is Your Brain on Sex: The Science Behind the Search for Love in paperback) and The Art of Risk: The New Science of Courage, Caution, and Chance – and is currently at work on a book about neuroenhancement.
Leanne Young, Executive Director of the new Brain Performance Institute at UT-Dallas Center for BrainHealth
After more than 20 years in engineering, Leanne Young joined the Center for BrainHealth to lead its Brain Performance Institute. Prior to joining the Brain Performance Institute, Leanne ran a division of Applied Research Associates, helping establish human vulnerability as a core business area for the firm. She is a nationally recognized expert in blast injury research and worked with the Department of Defense’s Combating Terrorism Technology Support Office to obtain the first histological evidence of primary blast-induced brain injuries. She also worked with DARPA to lead the first clinical trials of blast-induced brain injuries and, working with the Office of Naval Research, she led development of a computer model for planning the medical response to a blast attack on a ship.
Dr. Lew Lim, CEO & Founder of VieLight
Lew Lim is an engineer with a passion for helping people. He is the co-inventor of several wearable photobiomodulation (PBM) / low level light therapy devices, and has been recognized for the development of the intranasal light therapy systems, particularly to address neurological issues. He is a Doctor of Natural Medicine with additional diplomas in Medical Neuroscience and Business and Accountancy. He obtained his degrees and diplomas from the University of California at Berkeley, University of Sheffield, Duke University, Quantum University and The Chartered Institute of Management Accountants, UK.
Lisa Neuberger, Managing Director of Strategy + Innovation at Accenture Corporate Citizenship
Lisa Neuberger leads a global team to define strategic direction in areas such as social innovation, environmental sustainability and non-financial transparency. A social intrapreneur, she has a 19-year track record at Accenture managing teams to launch innovative initiatives such as AI4Good, new business lines in Sustainability and Public Service Value, a global Eco Champion program for employees, and a nonprofit consulting organization. She has also worked at the White House, the OECD, and CBS News—and holds graduate degrees from Wharton Business School and the Fletcher School of Law and Diplomacy at Tufts University.
Martina Ratto, Cognitive Scientist at MyCognition
Martina Ratto works at the London-based company MyCognition Ltd as a cognitive scientist, investigating the potential of cognitive assessment and training programmes in different clinical and real-world settings, and educating people in understanding how cognition works. She is also co-author of the award-winner paper “The Use of an IT-based Cognitive Assessment and Training as a part of a Smart City Program” presented at The Eleventh International Conference on Digital Society and eGovernments. Martina obtained a BA and MA degree from the University of Genoa, focusing on the theoretical foundations of cognitive science and the real-world applications of cognitive psychology and intelligent systems theories.
Nancy Briefs, President and CEO of Digital Cognition Technologies
Ms. Briefs’ is a serial entrepreneur, having helped successfully develop and commercialize innovative technologies with six med-tech startups. In July 2017, Ms. Briefs was appointed CEO & President of Digital Cognition Technologies (DCT), founded to market easy to administer and non-invasive tests to detect presymptomatic cognitive impairment. Prior to her work at DCT, Nancy Co-Founded and was the CEO of InfoBionic, a leading digital health platform for detection of cardiac arrhythmias. Having raised over $300M in venture capital and four successful liquidity events, she has proven the ability to lead teams from concept thru commercialization and value creation.
Neil Allison, Director of Business Model Innovation at Pearson North America
Neil is the director of Business Model Innovation at Pearson North America. Having Thirteen years of experience successfully building new markets for digital products and services. Neil has hands-on expertise across the ecosystem of education technology (learning and collaboration management, outcomes assessment, tutoring, digital content, and content distribution). His specialties include Business strategy and planning, new product strategy and development, customer and market development, strategic marketing, program strategy and design, higher education innovation.
Nikhil Sriraman, IP Analyst at SharpBrains
Nikhil Sriraman is a patent attorney admitted to practice before the United States Patent and Trademark Office (USPTO). Nikhil has held positions at the USPTO, IP law firms and in-house at Fortune 500 companies. He currently serves as eBay’s Intellectual Property Strategist, as well as SharpBrains’ IP Analyst. With degrees by DePaul University College of Law and the University of Michigan, Nikhil’s professional experience includes legal and engineering work at Ford and Johnson Controls.
Dr. Oliver Harrison, Chief Executive of the Health Moonshot at Telefónica Innovation
Dr. Oliver Harrison, a member of the World Economic Forum’s Council on the Future of Human Enhancement, runs an ambitious Health Moonshot at Telefónica Innovation. Prior to Telefónica, Dr. Harrison was a Senior Vice President with Healthways International, a Consultant to the World Health Organisation on mHealth for tackling Non-Communicable Diseases, and the Director of Strategy at the Health Authority-Abu Dhabi, where he helped drive a comprehensive reform of Abu Dhabi’s health system. Dr. Harrison spent five years with McKinsey healthcare practice and is a physician with US National Board Certification in Public Health, and Masters’ degrees in Public Health from Johns Hopkins and Neuroscience from Cambridge University.
Dr. Olivier Oullier, President of EMOTIV
Olivier Oullier, PhD, is a neuroscientist, strategist, and contributor to Fortune Magazine, He is the former Head of Strategy in Global Health and Healthcare and Member of the Executive Committee of the World Economic Forum, where he was in charge of an international project on value-based care involving more than 50 global companies and organizations. Olivier is a Full Professor of Behavioral and Brain Sciences at Aix-Marseille University and taught at the Universities of Oxford and Geneva’s executive education programs. His lab and applied research focus on consumer behavior, engagement, influence, social coordination dynamics, decision neuroscience.
Paul Lefrere, Innovation Lead at WEKIT — Wearable Experience for Knowledge Intensive Training
Dr. Paul Lefrere is the innovation lead of WEKIT. Previously, in such roles as Executive Director of eLearning for Microsoft in EMEA, he balanced Innovation, Execution and GoToMarket strategies, helping R&D evolve into winning products and services. As a PI/ co-PI/ advisor to multiple universities worldwide, he has led high-impact public-private sector projects involving Innovation, Change Management, Knowledge Management, Technology Management, Virtual Science Parks, Knowledge Media, IoT, Blockchain & Privacy.
Dr. Peter Reiner, Co-Founder of the National Core for Neuroethics at the University of British Columbia
Dr. Reiner’s current focus lies in Technologies of the Extended Mind and in the area of neuroethics, specializing in the non-medical impact of technology on the brain, with particular interests in the neuroethics of cognitive enhancement as well as the impact of modern technological society upon brain function. Dr. Reiner has a distinguished track record as a bench research scientist studying the neurobiology of behavioural states and neurodegenerative disease, and also was the President & CEO of Active Pass Pharmaceuticals, a drug discovery company that he founded to tackle the scourge of Alzheimer’s disease.
Dr. Randal Koene, Lead Scientist at Kernel
Dr. Randal Koene is the Lead Scientist at Kernel, a $100-million-funded start-up building advanced neural interfaces to treat disease and dysfunction, illuminate the mechanisms of intelligence, and extend cognition. A neuroscientist and neuroengineer, Dr. Koene also heads carboncopies.org, a nonprofit organisation trying to reverse engineer neural tissue and complete brains, and acts as Science Director of the 2045 Initiative. Previously, he was Director of Analysis at Halcyon Molecular and Director of the Department of Neuroengineering at Tecnalia, the third largest private research organization in Europe.
Dr. Ryan D’Arcy, President & Chief Scientific Officer of HealthTech Connex
Honoured as a Kickass Canadian, Dr Ryan D’Arcy co-founded HealthTech Connex in 2013 & serves as President & Chief Scientific Officer. Dr. D’Arcy is widely acknowledged as one of Canada’s leading neurotech innovators, with +200 publications, $80M in funding investment for healthtech & several breakthrough biotechnology products to market. He holds full professorship/endowed chair at Simon Fraser University, heads Surrey Memorial Hospital’s Health Sciences & Innovation & serves on numerous boards.
Sarah Lenz Lock, Senior Vice President for Policy at AARP and Executive Director of the Global Council on Brain Health (GCBH)
Sarah Lenz Lock is Senior Vice President for Policy in AARP’s Policy, Research and International Affairs (PRI), where she helps position AARP as a thought leader addressing the major issues facing older Americans. She leads AARP’s policy initiatives on brain health and care for people living with dementia, including serving as the Executive Director of the Global Council on Brain Health, an independent collaborative of scientists, doctors and policy experts convened by AARP to provide trusted information on brain health. Prior to joining AARP, she served as a Trial Attorney for the U.S. Department of Justice, handling complex litigation against federal agencies such as NIH, FDA, the Air Force and Army, and EPA.
Dr. Simone Schurle, Assistant Professor for Responsive Biomedical Systems at the Swiss Federal Institute of Technology
Dr. Schurle, a member of the World Economic Forum’s Council on the Future of Human Enhancement, is researching at the frontier of biomedical engineering. She graduated from the Karlsruhe Institute of Technology in Industrial Engineering and Management with specialization in micro/nanosystems, and then joined the Institute of Robotics and Intelligent Systems at the Swiss Federal Institute of Technology in Zurich, where she focused on magnetic manipulation techniques for biomedical applications. She was awarded with the ETH medal for her doctoral thesis and with fellowships from the SNSF, DAAD and the Society in Science – The Branco Weiss fellowship for her postdoctoral studies. She is also co-founder of MagnebotiX, a spin-off from ETHZ.
Tara Thiagarajan, Founder and Chief Scientist at Sapien Labs
Tara’s interest lies in understanding large-scale human systems and has worked on new analytical approaches to brain signals (LFP, ECoG and EEG) for over a decade. She has a BA in Mathematics from Brandeis University, an MBA from the Kellogg School of Management at Northwestern„ and a Ph.D. in Neuroscience from Stanford University. She did her postdoctoral research in neural network behaviour at the Section for Critical Brain Dynamics at the NIH and is a visiting scientist at National Centre for Biological Sciences.. She is also an Advisory Group Member at Ashoka Changemakers.
Thomas R. Insel, MD, President and Co-Founder of Mindstrong Health
Dr. Insel is a psychiatrist, neuroscientist, and currently a co-founder and President of Mindstrong Health. From 2002–2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Prior to serving as NIMH Director, Dr. lnsel was Professor of Psychiatry at Emory University where he was founding director of the Center for Behavioral Neuroscience in Atlanta. Most recently (2015 – 2017), he led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.
Dr. Walter Greenleaf, Medical VR/ AR Expert at Stanford Virtual Human Interaction Lab
Walter is a research scientist, entrepreneur, and medical product developer, known as an early pioneer in the medical application of virtual environment technology and viewed as one of the founders of the field. He has served as CEO and founder for InWorld Solutions, specializing in the therapeutic use of virtual worlds for behavioral health care, and Virtually Better, developing virtual environments for the treatment of phobias, anxiety disorders, and PTSD. He is Chief Science Officer for Pear Therapeutics and a founding Board Member of the International Society for Virtual Rehabilitation. Walter has also served as a scientific adviser and reviewer for the U.S. Public Health Service, National Science Foundation (NSF), National Institutes of Health (NIH), NASA, and the U.S. Department of Education.
Zack Lynch, General Partner at JAZZ Venture Partners
Zack Lynch is an entrepreneur, market maven and futurist who brings a rich understanding of the technologies and companies driving the experiential technology market to JAZZ. He is also the founder and Chairman of the Neurotechnology Industry Organization, and serves on the advisory boards of the McGovern Institute for Brain Research at MIT, Center for Neuroeconomic Studies at Claremont Graduate University, the Center for Neuroscience and Society at the University of Pennsylvania, as well as several private neurosoftware companies.
–> Learn more & Register for the 2017 SharpBrains Virtual Summit: Brain Enhancement in the Digital Age (December 5–7th).